In today's challenging deal environment, some #medtech companies are taking a solo path—launching their first medical devices independently, without traditional licensing or M&A. The challenge? Navigating complex regulatory pathways with limited experience. The solution? Partnering with high-quality contract development and manufacturing organizations (CDMOs). CDMOs provide expertise, specialized resources and advanced manufacturing capabilities to streamline the approval process and accelerate time to market. With cutting-edge technology and regulatory insights, they help mitigate risks and set companies up for successful launches. Learn more in our latest industry outlook: https://rsm.us/3VInsV4
"Exploring independent launches in the #medtech space is a bold move, but having the right partners—like experienced CDMOs—can make all the difference.